Anti-endothelial cell antibodies and central nervous system involvement in Behçet's disease

Clinics

Volumn 62, Issue 6, 2007, Pages 685-690

  Christmann De Souza, Romy B ^a   Lage, Laís ^a   Goldesntein Schainberg, Cláudia ^a   Macedo, André Regis ^a   Carrasco, Solange ^a   Gonçalves, Célio Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Beh et's disease, anti endothelial cell antibody; Central nervous system; Clinical disease activity; Prevalence

Indexed keywords

EID: 38549148763     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1807-59322007000600005     Document Type: Article

References (30)

1. Shimizu T, Erlich GE, Inaba G, Hayashi K. Behçet's disease. Sem Arthritis Rheum.1979;8:223-60.
2. Nazarro P. Cutaneous manifestations of Behçet's disease - Clinical and histopathological findings. In Monacelli M, Nazarro P, eds "Behçet's Disease" (M. Monacelli and P. Nazaro, Eds), pp.15-43, Karger, Basel/New York.1966.
3. Bang D, Honma T, Saito T, Nakagawa S, Ueki H, Lee S. Ultrastructure of vascular changes in cutaneous manifestations of Behçet's Disease. Acta Dermatol. Venerol. (Stockholm).1998;63:33-40.
4. O'Duffy JD. Vasculitis in Behçet's Disease. Rheum. Dis. Clin. North Am. 1990;16:423-431.
5. Calamia, KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet disease. Curr Opin Rheumatol.2004;17:1-8.
6. Orem A, Ertuk M, Cimsit G, Kural BV. Effect of plasma from patients with Behçet disease on the production of nitric oxide in cultured human umbilical vein endothelial cells. Med Princ Pract.2004;13:35-8.
7. Chambers JC Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol.2001;37:517-520.
8. Probs K, Fijnheer R, Rothova A. Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Am J Ophthalmol.2004;137: 850-87.
9. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S et al. Vascular involvement in Behçet's Disease. J Rheumatol.1992;19:402- 410.
10. Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol.1988;72:450-6.
11. Meroni PL, Khamashta MA, Youinou P, Shoenfeld Y. Mosaic of antiendothelial antibodies. Review of the first international workshop on antiendothelial antibodies: clinical and pathological significance Milan 9, November 1994. Lupus.1995;4:95-9.
12. Navarro M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G, et al. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus.1997;6:521-6.
13. Heurkens AH, Hiemstra PS, Lafeber GJ, Daha MR, Breedveld FC. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol.1989;78:7-12.
14. Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest.1984;73:611-25.
15. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum. 2001;44:1484-94.
16. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum.1997;40:551-61.
17. Nylander Lundqvist E, Back O, Nilsson TK, Rantapaa-Dahlqvist S. Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol.1992;11:248-53.
18. Aydintug AO, Tokgoz G, DÇruz DP, Gurler A, Cervera R, Duzgun N, et al. Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol.1993;67:157-62.
19. Cervera R, Navarro M, Lopez-Soto A, Cid MC, Font J, Esparza J et al. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity. Ann Rheum Dis.1994;53:265-67.
20. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet.1990;335:1078-80.
21. Kolluru GK, Tamilarasan KP, Geetha Priya S, Durgha NP, Chatterjee S. Cadmium induced endothelial dysfunction: consequence of defective migratory pattern of endothelial cells in association with poor nitric oxide availability under cadmium challenge. Cell Biol Int.2006;30:427-38.
22. Tamilarasan KP, Kolluru GK, Rajaram M, Indhumathy M, Saranya R, Chatterjee S. Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. BMC Cell Biol.2006;7:17.
23. Brodin E, Iversen N, Hansen JB. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase. J Lab Clin Med. 2006;147:167-73.
24. Lee KH; Bang D; Choi ES; Chun WH; Lee ES; Lee S. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res.1999;291:374-81.
25. Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol.1996;156:4946-51.
26. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behçet's disease (editorial). Clin Exp Rheumatol.1995;13:687-691.
27. Haznedaroglu IC, Özdemir O, Özcebe O, Dündar SV, Kirazli S. Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost.1996;75:974.
28. Pivetti-Pezzi P, Priori R, Catarinelli G, Meroni PL, Federici AB, Abdulaziz M, et al. Markers of vascular injury in Behcet's disease associated with retinal vasculitis. Ann Ophthalmol.1992;24:411-4.
29. Hirohata S, Takeuchu A, Miyamito T. Association of cerebrospinal fluid IgM index with central nervous system involvement in Behçet's disease. Arthritis Rheum.1986;29:793-6.
30. Sharief MK, Hentges R, Thomas E. Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease. Neurology.1991;41:1398-01.